+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Genomics Market Research Reports

Natural Killer (NK) cell therapy - Pipeline Insight, 2024 - Product Thumbnail Image

Natural Killer (NK) cell therapy - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 200 Pages
  • Global
From
Antisense Oligonucleotide Therapeutics - Pipeline Insight, 2024 - Product Thumbnail Image

Antisense Oligonucleotide Therapeutics - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 50 Pages
  • Global
From
Allogeneic Cell Therapies - Pipeline Insight, 2024 - Product Thumbnail Image

Allogeneic Cell Therapies - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Allogenic iNKT Cell Therapy - Pipeline Insight, 2024 - Product Thumbnail Image

Allogenic iNKT Cell Therapy - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Neo Antigen T-cell Therapy - Pipeline Insight, 2024 - Product Thumbnail Image

Neo Antigen T-cell Therapy - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
T cell therapy - Pipeline Insight, 2024 - Product Thumbnail Image

T cell therapy - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Gene and Cell Therapies in Rare Disorder - Pipeline Insight, 2024 - Product Thumbnail Image

Gene and Cell Therapies in Rare Disorder - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Gene therapy in Rare Diseases - Pipeline Insight, 2024 - Product Thumbnail Image

Gene therapy in Rare Diseases - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Gene And Cell Therapies Targeting Cns Disorders - Pipeline Insight, 2024 - Product Thumbnail Image

Gene And Cell Therapies Targeting Cns Disorders - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Gene Therapy For Ocular Rare Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Gene Therapy For Ocular Rare Disease - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
CRISPR therapies - Pipeline Insight, 2024 - Product Thumbnail Image

CRISPR therapies - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
AAV vectors in gene therapy - Pipeline Insight, 2024 - Product Thumbnail Image

AAV vectors in gene therapy - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 398 Pages
  • Global
From
EYS606 Market Size, Forecast, and Emerging Insight - 2032 - Product Thumbnail Image

EYS606 Market Size, Forecast, and Emerging Insight - 2032

  • Report
  • February 2024
  • 30 Pages
  • Global
From
RNA interference - Pipeline Insight, 2024 - Product Thumbnail Image

RNA interference - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 70 Pages
  • Global
From
From
From
From
From
From
From
Loading Indicator

The Genomics market is a sector of the biotechnology industry that focuses on the study of genomes, or the complete set of genetic material present in a living organism. It involves the sequencing, analysis, and manipulation of genetic material to understand the structure and function of genes, as well as their interactions with the environment. Genomics research is used to develop new treatments and diagnostics for diseases, as well as to improve crop yields and animal health. The Genomics market is composed of a variety of companies, ranging from large pharmaceutical companies to small start-ups. These companies are involved in the development of new technologies, such as gene editing, gene therapy, and gene sequencing, as well as the production of diagnostic tests and treatments. Some of the major players in the Genomics market include Illumina, Thermo Fisher Scientific, BGI, and Pacific Biosciences. Show Less Read more